3,4-Didehydro Alosetron

• CAT Number: R028545
• CAS Number: 122852-86-2
• Molecular Formula: C17H16N4O
• Molecular Weight: 292.342
• Purity: ≥95%
• Synonyms: 2,5-Dihydro-5-methyl-2-[(4-methyl-1H-imidazol-5-yl)methyl]-1H-pyrido[4,3-b]indol-1-one; 2,5-Dihydro-5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-1H-pyrido[4,3-b]indol-1-one
• Storage: -20°C
• IUPAC Name: 5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]pyrido[4,3-b]indol-1-one
• InChI: InChI=1S/C17H16N4O/c1-11-13(19-10-18-11)9-21-8-7-15-16(17(21)22)12-5-3-4-6-14(12)20(15)2/h3-8,10H,9H2,1-2H3,(H,18,19)
• InChIKey: CEMLEXILBQLXAX-UHFFFAOYSA-N
• SMILES: CC1=C(N=CN1)CN2C=CC3=C(C2=O)C4=CC=CC=C4N3C

3,4-Didehydro Alosetron is a derivative of Alosetron, a medication used to treat irritable bowel syndrome (IBS). This compound features a modified chemical structure, enhancing its potential pharmacological properties. Research focuses on its efficacy and safety in alleviating IBS symptoms, particularly in patients with severe diarrhea-predominant IBS, by blocking serotonin receptors in the gastrointestinal tract.